Hypotensive effect of endothelin-1 in nitric oxide-deprived, hypertensive pregnant rats

American Journal of Hypertension

Volumn 14, Issue 6 I, 2001, Pages 585-591

  Matz, Rachel L ^a   Van Overloop, Bruno ^a   Gairard, Alexis ^a  

^a CNRS   (France)

Author keywords

Endothelin 1; Hypotension; Nitric oxide; Preeclampsia; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR AGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE; NITRIC OXIDE; PHENYLEPHRINE; SARAFOTOXIN S6C;

ANIMAL MODEL; ARTICLE; BLOOD VESSEL TONE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; FEMALE; HEART RATE; HYPOTENSION; MEAN ARTERIAL PRESSURE; NONHUMAN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOOD PRESSURE; ENDOTHELIN-1; FEMALE; HYPOTENSION; NITRIC OXIDE; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN;

EID: 0034994544     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(00)01318-2     Document Type: Article

References (44)

1. Serial study of factors influencing changes in cardiac output during human pregnancy
2. Systemic hemodynamics and oxygen transport during pregnancy in chronically instrumented conscious rats
3. A study of angiotensin II pressor response throughout primigravid pregnancy
4. Decreased pressor responsiveness in pregnancy studies in experimental animals
5. Nitric oxide, the endothelium, pregnancy and pre-eclampsia
6. Pre-eclampsia: More than pregnancy-induced hypertension
7. The role of nitric oxide in the pathogenesis of pre-eclampsia
8. Plasma endothelin levels in pre-eclampsia: Elevation and correlation with uric acid levels and renal impairment
9. Plasma and urinary endothelin 1, prostacyclin metabolites and platelet consumption in pre-eclampsia and essential hypertensive pregnancy
10. Relationships between plasma endothelin 1 and prostacyclin in normal and preeclamptic pregnancy
11. Inhibition of nitric oxide synthesis and in vitro vascular reactivity in pregnant rats
12. Inhibition of nitric oxide synthesis in rats during pregnancy produces symptoms identical to pre-eclampsia
13. Animal models of preeclampsia
14. Long term nitric oxide blockade in the pregnant rat: Effects on blood pressure and plasma levels of endothelin-1
15. Localization and production of immunoreactive endothelin-1 in the trophoblast of human placenta
16. Biochemical characterization and autoradiographic localization of (125I)endothelin-1 binding sites on trophoblast and blood vessels of human placenta
17. Characterization of endothelin receptors in the human umbilical artery and vein
18. Endothelial modulation of vasoconstrictor responses to endothelin-1 in human placental stem villi small arteries
19. Relevance of vasoactive mediators for blood pressure effects of intravenous arachidonic acid injection in rats
20. In vivo pharmacology of Ro 46-2005, the first synthetic non peptide endothelin receptor antagonist: Implications for endothelin physiology
21. The role of nitric oxide in the regional vasodilator effects of endothelin-1 in the rat
22. Measurement of nitric oxide in biological models
23. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia and intrauterine growth retardation
24. L-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat
25. The effect of chronic nitric oxide synthesis inhibition on blood pressure and angiotensin II responsiveness in the pregnant rat
26. Identification of increased nitric oxide biosynthesis during pregnancy in rats
27. Endothelin and blood pressure regulation in the female rat: Studies in normal pregnancy and with nitric oxide synthase inhibition-induced hypertension
28. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney
29. Molecular pharmacology and pathophysiological significance of endothelin
30. B receptor mediates both vasodilation and vasoconstriction in vivo
31. B receptor antagonist Ro-46-8443
32. Biochemical and pharmacological profile of a potent and selective endothelin-B receptor antagonist, BQ-788
33. Effect of endothelin antagonists with or without BQ-788 on ET-1 responses in pithed rats
34. B receptors in rats
35. Human big-endothelin-1 and endothelin-1 release prostacyclin via the activation of ET1 receptors in the rat perfused lung
36. Endothelin receptor antagonists as new tools to inhibit endothelin induced vasoconstriction in humans: Comparison with calcium channel blockers
37. Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats
38. Endothelin-1 and relaxation of the rat aorta during pregnancy in nitroarginine-induced hypertension
39. Selectivity of oral versus intravenous aspirin in rats
40. Prostaglandins maintain renal vasodilation and hyperfiltration during chronic nitric oxide synthase blockade in conscious pregnant rats
41. Possible involvement of endothelium-derived hyperpolarizing factor in vascular responses of abdominal aorta from pregnant rats
42. Autocrine role for the endothelin-B receptor in the secretion of adrenomedullin
43. G-nitro-L-arginine methyl ester